GlassScriptPhysician profile
Jennifer V Crocker
NPI 1356445878
$15,721.28
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Pediatric Rehabilitation Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,710 · 2020: $4,299 · 2021: $1,922 · 2022: $6,791.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $14,263.62 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $173.95 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $173.14 | 2019-2020 | |
| Greenwich Biosciences, INC. | $150.71 | 2019-2021 | |
| Ptc Therapeutics, INC. | $113.80 | 2019-2022 | |
| Medtronic, INC. | $78.95 | 2021 | |
| Eisai INC. | $74.17 | 2019-2022 | |
| Aquestive Therapeutics, INC. | $60.59 | 2019 | |
| Jazz Pharmaceuticals INC. | $57.55 | 2022 | |
| Ucb, INC. | $57.00 | 2019-2021 | |
| Ns Pharma, INC. | $54.64 | 2021-2022 | |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $54.51 | 2019-2021 | |
| Allergan, INC. | $47.73 | 2020-2021 | |
| Neurelis, INC. | $46.01 | 2021 | |
| Biogen, INC. | $42.86 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $35.78 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.56 | 2019-2022 | |
| Genzyme Corporation | $24.50 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.00 | 2022 | |
| Travere Therapeutics, INC. | $20.05 | 2019 | |
| Sarepta Therapeutics, INC. | $20.05 | 2021 | |
| Metacel Pharmaceuticals LLC | $19.40 | 2022 | |
| Medtronic USA, INC. | $18.56 | 2019 | |
| Cranial Technologies, INC | $17.27 | 2020 | |
| Piramal Critical Care | $16.74 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.64 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.53 | 2022 | |
| Zogenix INC. | $10.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Crocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.